Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
5.74
+0.14 (2.50%)
At close: Feb 21, 2025, 4:00 PM
5.90
+0.16 (2.79%)
After-hours: Feb 21, 2025, 5:24 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $11.49 million as of February 21, 2025. Its market cap has decreased by -35.88% in one year.
Market Cap
11.49M
Enterprise Value
18.78M
1-Year Change
-35.88%
Ranking
Category
Stock Price
$5.74
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $11.49M, a decrease of -80.38%. That is a compound annual growth rate of -38.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 11.49M | 32.87% |
| Dec 31, 2024 | 8.65M | -63.39% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 795.78B |
| UnitedHealth Group | 420.35B |
| Johnson & Johnson | 389.50B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.11B |
| Abbott Laboratories | 234.18B |
| AstraZeneca | 227.07B |
| Merck & Co. | 225.26B |